Peter Tai-Ching Ho

Chief Development Officer, Epizyme, Inc.

Companies

Aravive, Inc.Board member May 21, 2021 to Oct 27, 2022¹
Epizyme, Inc.Chief Development Officer Sep 15, 2014 to Oct 25, 2017²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aravive, Inc.110,706 shares³Oct 24, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 24, 2022Granted 54,353 shares at $0.92 of Aravive, Inc.⁴
Oct 24, 2022Granted 54,353 shares at $0.92 of Aravive, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAravive, Inc., Board member
2
SEC EDGAREpizyme, Inc., Chief Development Officer
3
SEC EDGARAravive, Inc. shares after the filing of Oct 24, 2022
4
SEC EDGARForm 4 filed Oct 27, 2022